HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

T 107

cytotoxic LHRH agonist; less toxic than doxorubicin by itself
Also Known As:
AN-152; LHRH, lysine(6)-doxorubicin; Lys(6)-LHRH-doxorubicin; T-107
Networked: 27 relevant articles (4 outcomes, 9 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Schally, Andrew V: 16 articles (05/2013 - 09/2002)
2. Nagy, Attila: 9 articles (11/2005 - 09/2002)
3. Halmos, Gabor: 6 articles (05/2013 - 09/2003)
4. Schally, A V: 5 articles (05/2013 - 08/2000)
5. Szepeshazi, Karoly: 4 articles (05/2013 - 10/2003)
6. Block, Norman L: 4 articles (05/2013 - 01/2011)
7. Gründker, Carsten: 4 articles (01/2009 - 09/2002)
8. Emons, Günter: 4 articles (01/2009 - 09/2002)
9. Szalontay, Luca: 3 articles (05/2013 - 07/2012)
10. Vidaurre, Irving: 3 articles (05/2013 - 07/2012)

Related Diseases

1. Neoplasms (Cancer)
2. Endometrial Neoplasms (Endometrial Cancer)
3. Prostatic Neoplasms (Prostate Cancer)
4. Ovarian Neoplasms (Ovarian Cancer)
5. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. Gonadotropin-Releasing Hormone (GnRH)
2. Doxorubicin (Adriamycin)
3. AN 207
4. LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)
5. AN 204 (AN 201)
6. Hormones
7. Estrogens (Estrogen)
8. Messenger RNA (mRNA)
9. Epidermal Growth Factor Receptor (EGF Receptor)
10. Epidermal Growth Factor (EGF)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Drug Therapy (Chemotherapy)
3. Aftercare (After-Treatment)
4. Injections